Schrodinger (SDGR) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

SDGR Schrodinger

Watchlist

19.770
-0.530-2.61%

Close Dec 27 16:00 ET

19.770
0.0000.00%

Post 20:01 ET

1.44BMarket Cap-8.07P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

2024's 'Biggest Loses' That Could See Reversal in 2025
Seeking AlphaDec 23 10:00 ET
AI Driven Drug Discovery Patent Landscape Report 2024: 1,087 Patents Analyzed With Market Sales Data and Growth Rates - ResearchAndMarkets.com
BusinesswireDec 20 07:23 ET
Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler
Seeking AlphaDec 3 13:52 ET
Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference
BusinesswireNov 20 08:30 ET
Express News | Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersNov 19 08:30 ET
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BusinesswireNov 19 08:30 ET

Comments

Big bull Salvekar

Nov 12 11:20

150 million upfront payment from Novartis ❤️❤️🚀🚀

$Schrodinger (SDGR.US)$
bringing stock back to 30+
$Exscientia (Delisted) (EXAI.US)$ $Recursion Pharmaceuticals (RXRX.US)$ $NVIDIA (NVDA.US)$

Jaguar8

Nov 12 05:55

NEWS ER

$Schrodinger (SDGR.US)$
Schrödinger Reports Third Quarter 2024 Financial Results
Schrödinger (SDGR) reported Q3 2024 financial results with total revenue of $35.3 million, down from $42.6 million in Q3 2023. Software revenue increased 10% to $31.9 million, while drug discovery revenue decreased to $3.4 million. The company announced a new collaboration with Novartis, receiving $150 million upfront with potential milestone payments up to $2.3 billion. Operating expenses rose to $86.2 millio...

Jaguar8

Nov 12 05:47

NEWS

$Schrodinger (SDGR.US)$
Schrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis
Schrödinger to receive $150 million upfront and eligible to receive up to approximately $2.3 billion in milestone payments plus royalties
Expanded multi-year software agreement enables technology deployment at significant scale across Novartis's global research organization
Schrödinger to host third quarter 2024 financial results webcast today at 8:00 a.m. ET
Schröd...